You are here: Industry Insights > Drug approvals

News List

Global approvals of new innovative drugs by Chinese biotech companies Deborah Seah
February 20, 2023
Novel Drug approvals in 2022；Approval of Chinese drug potentials in the global market.
FDA new drug approvals up 11% in 2018 biospectrumasia
August 01, 2019
“PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2019 Edition” reveals that mega cap bio/pharma companies received 17 novel approvals in 2018
Special Report—2 years after sluggish 2016, new drug approvals hit their stride in 2018 fiercebiotech
January 04, 2019
If in 2017, the FDA was trying to make up for lost time, the agency went into overdrive in 2018, approving more than 50 new molecular entities.....
2017: A Year of Innovation and Advances FDA
February 09, 2018
CDER’s drug therapy approvals of 2017 will help a wide range of patients suffering from many different diseases while many new treatment options for patients in need.
3 Biopharmas Worth Watching in 2018 biospace
January 16, 2018
Because of changes to the tax code, many investors are hoping M&A activity will pick up. Others are just hoping they can get a handle on rising stocks. Here are three biopharma stocks worth keeping an eye on.
Opportunity or challenge? Favorable policies promote the increase of drug approval(1) en-cphi.cn
October 18, 2017
The U.S. Food and Drug Administration (FDA) is taking advantage of policy groundwork laid in past years to speed drug approvals.
NICE gets go-ahead to fast-track more drug approvals europeanpharmaceuticalreview
March 16, 2017
Patients are set to benefit from more rapid access to the most cost-effective treatments after proposed changes to the NICE drug evaluation process were approved.